RGNX Competitors & Alternatives
Compare Regenxbio Inc with similar stocks in the same industry
Biotechnology
RGNX
Main Stock$12.29
Tradestie Score
62
Market Cap
$493.52M
Revenue Growth
-0.9%
Analyst Upside
+98.2%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OLMA
Olema Pharmaceuticals, Inc. Common Stock
|
$11.85
|
$757.72M | - | 61 | Compare |
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$32.54
|
$748.90M | - | 58 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$16.92
|
$726.21M | 7.6 | 52 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$22.98
|
$718.62M | - | 61 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$32.88
|
$715.25M | - | 61 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$149.68
|
$699.30M | - | 60 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.34
|
$688.47M | - | 53 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
ARVN
Arvinas, Inc
|
$8.27
|
$670.30M | - | 54 | Compare |
More RGNX Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry